- cafead   Jul 26, 2024 at 11:02: AM
via It’s what biopharma CEOs dream of: winning an approval for a drug they’ve helped develop and delivering it to patients. With its PDUFA date slated for Aug. 13, Citius Pharmaceuticals is on that path with Lymphir, an immunotherapy for a rare blood cancer.
article source
article source